Evidence map›Paper›PMID 25562791›Full record

ArticleVaccine2015

A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.

Guorui Xie, Huanle Luo, Bing Tian, Brian Mann, Xiaoyong Bao, Jere McBride, Robert Tesh, Alan D Barrett, Tian Wang

Abstract read
In one paragraph

Article in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Guorui XieDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Huanle LuoDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Bing TianDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Brian MannDepartment of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Xiaoyong BaoDepartment of Pediatrics, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Jere McBrideDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555 USA.
Robert TeshDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555 USA.
Alan D BarrettDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555 USA.
Tian WangDepartment of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, The University of Texas Medical Branch, Galveston, TX 77555 USA. Electronic address: ti1wang@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus InfectionR01AI072060 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2008 to 2012
$1.9M
Rational Development of Candidate Attenuated Flavivirus VaccinesR01AI099123 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2013 to 2016
$1.8M
NIAID NIH HHS R01 AI072060NIAID NIH HHS R01AI072060NIAID NIH HHS R01 AI099123
6 · The paper itself

Abstract

Previous studies have shown that an attenuated West Nile virus (WNV) nonstructural (NS) 4B-P38G mutant induces stronger innate and adaptive immune responses than wild-type WNV in mice, which has important applications to vaccine development. To investigate the mechanism of immunogenicity, we characterized WNV NS4B-P38G mutant infection in two human cell lines-THP-1 cells and THP-1 macrophages. Although the NS4B-P38G mutant produced more viral RNA than the parental WNV NY99 in both cell types, there was no detectable infectious virus in the supernatant of either cell type. Nonetheless, the attenuated mutant boosted higher innate cytokine responses than virulent parental WNV NY99 in these cells. The NS4B-P38G mutant infection of THP-1 cells led to more diverse and robust innate cytokine responses than that seen in THP-1 macrophages, which were mediated by toll-like receptor (TLR)7 and retinoic acid-inducible gene 1(RIG-I) signaling pathways. Overall, these results suggest that a defective viral life cycle during NS4B-P38G mutant infection in human monocytic and macrophage cells leads to more potent cell intrinsic innate cytokine responses.

Indexed as

AnimalsCell LineCytokinesHumansInterleukin-12Interleukin-1betaInterleukin-6MacrophagesMiceMonocytesPolymerase Chain ReactionRNA, ViralTumor Necrosis Factor-alphaWest Nile virusCytokinesInterleukin-12Interleukin-1betaInterleukin-6RNA, ViralTumor Necrosis Factor-alphaCytokineImmune responseNS4B proteinWest Nile virus

Identifiers

PMID25562791
PMCPMC4312757
OpenAlexW2080925929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.